Allarity Therapeutics Inc (ALLR)

Allarity Therapeutics Inc (ALLR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $13.9M; returns 1 day +2.2%, 1 week -3.3%, 1 year -37.7%.

Allarity Therapeutics Inc. is a clinical-stage pharmaceutical company primarily focused on developing personalized cancer treatments, leveraging its proprietary Drug Response Predictor (DRP®) technology to identify patients most likely to respond to specific drug therapies.

Groups ALLR belongs to

• Clinical Stage Biotech
• Biotechnology
• Oncology
• Pharmaceuticals
• Precision Medicine
• Personalized Medicine
• Ovarian Cancer
• Cancer Therapeutics
• Healthcare
• Fast Track Designation
• Clinical Stage

ALLR financial model: income statement, cash flow and balance sheet